Literature DB >> 24008181

Diagnostic work-up and surgery in participants of the Gdansk lung cancer screening programme: the incidence of surgery for non-malignant conditions.

Witold Rzyman1, Malgorzata Jelitto-Gorska, Robert Dziedzic, Iwona Biadacz, Janina Ksiazek, Piotr Chwirot, Tomasz Marjanski.   

Abstract

OBJECTIVES: Low-dose computed tomography (LDCT) screening improves lung cancer prognosis but also results in diagnostic work-up and surgical treatment in many individuals without cancer. Therefore, we analysed the procedures that screening participants underwent to better understand the extent of overdiagnosis.
METHODS: Between 2009 and 2011, 8649 healthy volunteers aged 50-75 years with a 20 pack-year smoking history underwent LDCT screening, of whom individuals with detected lung nodules had 2 years control. Participants with a nodule >10 mm in diameter or with suspected tumour morphology underwent diagnostic work-up: 283 (6%)/4694 (54%) screened participants had detected lung nodules. One hundred and four individuals underwent surgery, 27 underwent oncological treatment and 152 without a cancer diagnosis underwent further follow-up with LDCT.
RESULTS: In 75% of participants accepted for diagnostic work-up and 25% of surgical patients, the procedures were unnecessary. In 70 (24.7%) participants, a specific diagnosis was obtained mainly due to the low efficacy of fine needle aspiration biopsy [sensitivity, 65.2%; negative predictive value (NPV), 95.9%] and bronchofiberoscopy (sensitivity, 71.4%; NPV, 50%) caused by overinterpretation of LDCT [positive predictive value (PPV), 2%]. Of 104 (36.7%) surgical patients, 43 (41.4%) had a preoperative cancer diagnosis, and 61 (58.6%) underwent surgery without pathological examination. In the latter group, intervention was justified in 35 (57.3%) patients. Complications occurred in 49 (17.3%) participants subjected to diagnostic work-up. In surgical patients, 67 (64.4%) malignant and 37 (35.6%) benign lesions were resected. In the latter group, intervention was justified in only 11 (29.7%) patients. No patient died because of diagnostic or treatment procedures during the study. The complication rate was 14.5% in the malignant and 10.8% in the benign groups. A neoplasm was found in 94 screening participants, of whom 67 (71.3%) underwent surgery; the remaining 27 (28.7%) patients were not surgical candidates. Adenocarcinoma accounted for 49/67 (73%) patients who underwent surgery for non-small-cell lung cancer (NSCLC); 56/67 (84%) patients had stage I NSCLC, and 26/67 (38%) underwent video-assisted thoracoscopic surgery lobectomy.
CONCLUSIONS: Futile diagnostic work-ups and operations must be reduced before LDCT screening can be broadly used. Stage I adenocarcinoma dominated in the NSCLC patients who underwent surgery.

Entities:  

Keywords:  Early detection; Low-dose computed tomography; Lung cancer; Screening; Surgery

Mesh:

Year:  2013        PMID: 24008181      PMCID: PMC3829503          DOI: 10.1093/icvts/ivt388

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  25 in total

1.  Transcutaneous computed bioconductance measurement in lung cancer: a treatment enabling technology useful for adjunctive risk stratification in the evaluation of suspicious pulmonary lesions.

Authors:  Rex C Yung; Ming Ying Zeng; Gregory J Stoddard; Michael Garff; Karleen Callahan
Journal:  J Thorac Oncol       Date:  2012-04       Impact factor: 15.609

2.  Surgical procedures in the DANTE trial, a randomized study of lung cancer early detection with spiral computed tomography: comparative analysis in the screening and control arm.

Authors:  Maurizio Infante; Giuseppe Chiesa; Daniel Solomon; Emanuela Morenghi; Eliseo Passera; Fabio Romano Lutman; Edoardo Bottoni; Umberto Cariboni; Valentina Errico; Emanuele Voulaz; Giorgio Ferraroli; Alberto Testori; Francesco Inzirillo; Maurizio Chiarenza; Massimo Roncalli; Silvio Cavuto; Arturo Chiti; Marco Alloisio; Gianluigi Ravasi
Journal:  J Thorac Oncol       Date:  2011-02       Impact factor: 15.609

Review 3.  Screening and early detection of lung cancer.

Authors:  Susan C Van't Westeinde; Rob J van Klaveren
Journal:  Cancer J       Date:  2011 Jan-Feb       Impact factor: 3.360

4.  Reduced lung-cancer mortality with low-dose computed tomographic screening.

Authors:  Denise R Aberle; Amanda M Adams; Christine D Berg; William C Black; Jonathan D Clapp; Richard M Fagerstrom; Ilana F Gareen; Constantine Gatsonis; Pamela M Marcus; JoRean D Sicks
Journal:  N Engl J Med       Date:  2011-06-29       Impact factor: 91.245

Review 5.  Overview of observational studies of low-dose helical computed tomography screening for lung cancer.

Authors:  Renee L Manser; Louis B Irving; Margaret P de Campo; Michael J Abramson; Christine A Stone; Karen E Pedersen; Mark Elwood; Donald A Campbell
Journal:  Respirology       Date:  2005-01       Impact factor: 6.424

6.  CT screening for lung cancer: five-year prospective experience.

Authors:  Stephen J Swensen; James R Jett; Thomas E Hartman; David E Midthun; Sumithra J Mandrekar; Shauna L Hillman; Anne-Marie Sykes; Gregory L Aughenbaugh; Aaron O Bungum; Katie L Allen
Journal:  Radiology       Date:  2005-02-04       Impact factor: 11.105

7.  Baseline characteristics of participants in the randomized national lung screening trial.

Authors:  Denise R Aberle; Amanda M Adams; Christine D Berg; Jonathan D Clapp; Kathy L Clingan; Ilana F Gareen; David A Lynch; Pamela M Marcus; Paul F Pinsky
Journal:  J Natl Cancer Inst       Date:  2010-11-22       Impact factor: 13.506

8.  Screening for early lung cancer with low-dose spiral computed tomography: results of annual follow-up examinations in asymptomatic smokers.

Authors:  Stefan Diederich; Michael Thomas; Michael Semik; Horst Lenzen; Nikolaus Roos; Anushe Weber; Walter Heindel; Dag Wormanns
Journal:  Eur Radiol       Date:  2004-01-16       Impact factor: 5.315

9.  Early lung-cancer detection with spiral CT and positron emission tomography in heavy smokers: 2-year results.

Authors:  Ugo Pastorino; Massimo Bellomi; Claudio Landoni; Elvio De Fiori; Patrizia Arnaldi; Maria Picchio; Giuseppe Pelosi; Peter Boyle; Ferruccio Fazio
Journal:  Lancet       Date:  2003-08-23       Impact factor: 79.321

10.  Results of three-year mass screening programme for lung cancer using mobile low-dose spiral computed tomography scanner.

Authors:  S Sone; F Li; Z G Yang; T Honda; Y Maruyama; S Takashima; M Hasegawa; S Kawakami; K Kubo; M Haniuda; T Yamanda
Journal:  Br J Cancer       Date:  2001-01-05       Impact factor: 7.640

View more
  10 in total

1.  eComment. Positron emission tomography reduces the incidence of surgery for non-malignant conditions in lung cancer screening programmes.

Authors:  Paolo Scanagatta; Stefano Sestini
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-12

2.  Recommendations from the European Society of Thoracic Surgeons (ESTS) regarding computed tomography screening for lung cancer in Europe.

Authors:  Jesper Holst Pedersen; Witold Rzyman; Giulia Veronesi; Thomas A D'Amico; Paul Van Schil; Laureano Molins; Gilbert Massard; Gaetano Rocco
Journal:  Eur J Cardiothorac Surg       Date:  2017-03-01       Impact factor: 4.191

3.  Efficacy of thoracoscopic anatomical segmentectomy for small pulmonary nodules.

Authors:  Hui Li; Yang Liu; Bao-Cun Ling; Bo Hu
Journal:  World J Clin Cases       Date:  2020-06-06       Impact factor: 1.337

Review 4.  A narrative review of invasive diagnostics and treatment of early lung cancer.

Authors:  Robert Dziedzic; Tomasz Marjański; Witold Rzyman
Journal:  Transl Lung Cancer Res       Date:  2021-02

5.  Futile lobectomies following video-thoracoscopic exploration for indeterminate pulmonary nodules: a retrospective study.

Authors:  Gabrielle Drevet; Yaniss Belaroussi; Michael Duruisseaux; Lara Chalabreysse; Renaud Grima; Jean-Michel Maury; François Tronc
Journal:  J Thorac Dis       Date:  2022-08       Impact factor: 3.005

6.  The multidisciplinary team plays an important role in the prediction of small solitary pulmonary nodules: a propensity-score-matching study.

Authors:  Chaoyuan Liu; Lishu Zhao; Fang Wu; Yeqian Feng; Rong Jiang; Chunhong Hu
Journal:  Ann Transl Med       Date:  2019-12

7.  Serum Metabolite Profiles in Participants of Lung Cancer Screening Study; Comparison of Two Independent Cohorts.

Authors:  Piotr Widłak; Karol Jelonek; Agata Kurczyk; Joanna Żyła; Magdalena Sitkiewicz; Edoardo Bottoni; Giulia Veronesi; Joanna Polańska; Witold Rzyman
Journal:  Cancers (Basel)       Date:  2021-05-31       Impact factor: 6.639

8.  Incidentally diagnosed pulmonary nodule: a diagnostic algorithm.

Authors:  Robert Dziedzic; Witold Rzyman
Journal:  Kardiochir Torakochirurgia Pol       Date:  2014-11-30

Review 9.  Metabolome-based biomarkers: their potential role in the early detection of lung cancer.

Authors:  Karol Jelonek; Piotr Widłak
Journal:  Contemp Oncol (Pozn)       Date:  2018-09-30

10.  Screening for Lung Cancer: CHEST Guideline and Expert Panel Report.

Authors:  Peter J Mazzone; Gerard A Silvestri; Lesley H Souter; Tanner J Caverly; Jeffrey P Kanne; Hormuzd A Katki; Renda Soylemez Wiener; Frank C Detterbeck
Journal:  Chest       Date:  2021-07-13       Impact factor: 9.410

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.